Prevalence of suspected nonalcoholic fatty liver disease in hispanic/latino individuals differs by heritage

Clinical Gastroenterology and Hepatology

Volumn 13, Issue 3, 2015, Pages 569-576

  Kallwitz, Eric R ^a   Daviglus, Martha L ^b   Allison, Matthew A ^c   Emory, Kristen T ^c   Zhao, Lihui ^b   Kuniholm, Mark H ^d   Chen, Jinsong ^b   Gouskova, Natalia ^e   Pirzada, Amber ^b   Talavera, Gregory A ^f   Youngblood, Marston E ^e   Cotler, Scott J ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF NORTH CAROLINA   (United States)

^f SAN DIEGO STATE UNIVERSITY   (United States)

Author keywords

HCHS SOL; Hispanic americans; Life style; Obesity; Steatohepatitis

Indexed keywords

AMINOTRANSFERASE;

ADULT; ALCOHOL CONSUMPTION; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; COHORT ANALYSIS; CUBAN; CULTURAL FACTOR; DIET; DISEASE ASSOCIATION; EDUCATIONAL STATUS; ENVIRONMENTAL FACTOR; FEMALE; HEALTH BEHAVIOR; HISPANIC; HUMAN; INCOME; INHERITANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MEXICAN; MIDDLE AGED; MULTICENTER STUDY; NONALCOHOLIC FATTY LIVER; PHYSICAL ACTIVITY; PREVALENCE; PUERTO RICAN; SEROLOGY; SEX DIFFERENCE; SLEEP; ADOLESCENT; AGED; CLINICAL TRIAL; NON-ALCOHOLIC FATTY LIVER DISEASE; RISK FACTOR; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; FEMALE; HISPANIC AMERICANS; HUMANS; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; PREVALENCE; RISK FACTORS; YOUNG ADULT;

EID: 84925378196     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2014.08.037     Document Type: Article

References (28)

1. Vernon G., Baranova A., Younossi Z.M. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 2011, 34:274-285.
2. Angulo P. Long-term mortality in nonalcoholic fatty liver disease: is liver histology of any prognostic significance?. Hepatology 2010, 51:373-375.
3. Soderberg C., Stal P., Askling J., et al. Decreased survival of subjects with elevated liver function tests during a 28-year follow-up. Hepatology 2010, 51:595-602.
4. Kallwitz E.R., Guzman G., TenCate V., et al. The histologic spectrum of liver disease in African-American, non-Hispanic white, and Hispanic obesity surgery patients. Am J Gastroenterol 2009, 104:64-69.
5. Browning J.D., Szczepaniak L.S., Dobbins R., et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004, 40:1387-1395.
6. Clark J.M., Brancati F.L., Diehl A.M. The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol 2003, 98:960-967.
7. Williams C.D., Stengel J., Asike M.I., et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liverbiopsy: a prospective study. Gastroenterology 2011, 140:124-131.
8. Flores G., Fuentes-Afflick E., Barbot O., et al. The health of Latino children: urgent priorities, unanswered questions, and a research agenda. JAMA 2002, 288:82-90.
9. Ogden C.L., Carroll M.D., Kit B.K., et al. Prevalence of childhood and adult obesity in the United States, 2011-2012. JAMA 2014, 311:806-814.
10. Ortiz-Lopez C., Lomonaco R., Orsak B., et al. Prevalence of prediabetes and diabetes and metabolic profile of patients with nonalcoholic fatty liver disease (NAFLD). Diabetes Care 2012, 35:873-878.
11. Romeo S., Kozlitina J., Xing C., et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet 2008, 40:1461-1465.
12. Ford E.S., Giles W.H., Dietz W.H. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002, 287:356-359.
13. Lomonaco R., Ortiz-Lopez C., Orsak B., et al. Role of ethnicity in overweight and obese patients with nonalcoholic steatohepatitis. Hepatology 2011, 54:837-845.
14. Bambha K., Belt P., Abraham M., et al. Ethnicity and nonalcoholic fatty liver disease. Hepatology 2012, 55:769-780.
15. Lara M., Akinbami L., Flores G., et al. Heterogeneity of childhood asthma among Hispanic children: Puerto Rican children bear a disproportionate burden. Pediatrics 2006, 117:43-53.
16. Sorlie P.D., Aviles-Santa L.M., Wassertheil-Smoller S., et al. Design and implementation of the Hispanic Community Health Study/Study of Latinos. Ann Epidemiol 2010, 20:629-641.
17. Solga S., Alkhuraishe A.R., Clark J.M., et al. Dietary composition and nonalcoholic fatty liver disease. Dig Dis Sci 2004, 49:1578-1583.
18. Toshimitsu K., Matsuura B., Ohkubo I., et al. Dietary habits and nutrient intake in non-alcoholic steatohepatitis. Nutrition 2007, 23:46-52.
19. National Cholesterol Education Program Expert Panel on Detection E, Treatment of High Blood Cholesterol in Adults: Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002, 106:3143-3421.
20. Lavange L.M., Kalsbeek W.D., Sorlie P.D., et al. Sample design and cohort selection in the Hispanic Community Health Study/Study of Latinos. Ann Epidemiol 2010, 20:642-649.
21. Daviglus M.L., Talavera G.A., Aviles-Santa M.L., et al. Prevalence of major cardiovascular risk factors and cardiovascular diseases among Hispanic/Latino individuals of diverse backgrounds in the United States. JAMA 2012, 308:1775-1784.
22. Schwimmer J.B., Celedon M.A., Lavine J.E., et al. Heritability of nonalcoholic fatty liver disease. Gastroenterology 2009, 136:1585-1592.
23. Sans M. Admixture studies in Latin America: from the 20th to the 21st century. Hum Biol 2000, 72:155-177.
24. Davis J.N., Le K.A., Walker R.W., et al. Increased hepatic fat in overweight Hispanic youth influenced by interaction between genetic variation in PNPLA3 and high dietary carbohydrate and sugar consumption. Am J Clin Nutr 2010, 92:1522-1527.
25. Fracanzani A.L., Valenti L., Bugianesi E., et al. Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes. Hepatology 2008, 48:792-798.
26. Prati D., Taioli E., Zanella A., et al. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med 2002, 137:1-10.
27. Elinav E., Ben-Dov I.Z., Ackerman E., et al. Correlation between serum alanine aminotransferase activity and age: an inverted U curve pattern. Am J Gastroenterol 2005, 100:2201-2204.
28. Browning J.D., Kumar K.S., Saboorian M.H., et al. Ethnic differences in the prevalence of cryptogenic cirrhosis. Am J Gastroenterol 2004, 99:292-298.